Taisho Pharmaceutical Co., Ltd.
Records under this name other than the patents Taisho Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Back to Taisho Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,022,389 | Prophylactic or Therapeutic Drug for Constipation Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 11,365,192 | Pyridine compound substituted with azole Lapsed on the fee record Ended Jun 21, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2026 | USPTO record |
| US 8,609,847 | Dihydroquinolinone derivatives Lapsed on the fee record Ended Dec 17, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 17, 2025 | USPTO record |
| US 9,695,148 | 2-Pyridone Compound Formerly held Lapsed on the fee record Ended Jul 4, 2025 · High confidence | Lapsed on the fee record | Ended Jul 4, 2025 | High confidence |
| US 8,466,113 | 4-isopropylphenyl glucitol compounds as SGLT1 inhibitors Lapsed on the fee record Ended Jun 18, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 18, 2025 | USPTO record |
| US 9,522,914 | Azole derivative Lapsed on the fee record Ended Dec 20, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 20, 2024 | USPTO record |
| US 9,499,477 | Hydroxamic acid derivative Lapsed on the fee record Ended Nov 22, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 22, 2024 | USPTO record |
| US 9,422,240 | Partially saturated nitrogen-containing heterocyclic compound Lapsed on the fee record Ended Aug 23, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 23, 2024 | USPTO record |
| US 8,193,176 | Phenylpyrazole derivatives Lapsed on the fee record Ended Jun 5, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 5, 2024 | USPTO record |
| US 8,183,387 | Phenylpyrazole derivatives Lapsed on the fee record Ended May 22, 2024 · USPTO record | Lapsed on the fee record | Ended May 22, 2024 | USPTO record |